NEOJF yields 2.73% · JNJ yields 2.13%● Live data
📍 NEOJF pulled ahead of the other in Year 1
Combined, NEOJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NEOJF + JNJ for your $10,000?
NEOJAPAN Inc. engages in development and sale of packaged software to small and medium-sized enterprises, large companies, schools, hospitals, local governments, and public agencies in Japan and internationally. The company offers desknet's NEO, a groupware software; AppSuite, a tool to create custom business applications; and ChatLuck, a chat-based business communication tool. It also provides Denbun, a web-based email system for corporate clients that manages, sends, and receives emails through a web browser; desknet's DAX, a file transfer system; desknet's SSS, a web-based sales management system, which enables to monitor progress in business negotiations, client info, and sales; and desknet's CAMS, a web-based customer relationship management system. In addition, it provides multi-application integration and hosting services; and system integration services, such as e-business system, e-commerce website, infrastructure and middleware, application service provider website construction, and online information distribution services. The company was incorporated in 1992 and is headquartered in Yokohama, Japan.
Full NEOJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.